Document is current
Any future updates will be listed below
-
Authors
Chiba, Shigeru https://orcid.org/0000-0001-7803-7338
Sakata-Yanagimoto, Mamiko https://orcid.org/0000-0001-7310-8045
-
Funding
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science (KAKENHI #19H03684)
Japan Agency for Medical Research and Development (cm0106505h, lm0203097h)
- License Information
-
More Information
Article History
Received: 10 May 2020
Revised: 27 June 2020
Accepted: 14 July 2020
First Online: 23 July 2020
Compliance with ethical standards
:
: The authors are conducting a phase II clinical trial of dasatinib in AITL and other Tfh lymphoma patients with a drug supply from Bristol-Meyer Squibb that sells dasatinib.
